Skip Navigation



Nucleic Acids Research Advance Access published online on July 13, 2009

Nucleic Acids Research, doi:10.1093/nar/gkp582
This Article
Right arrow Full Text Freely available
Right arrow Print PDF (2204K) Freely available
Right arrow Screen PDF (1356K) Freely available
Right arrow Supplementary Data
Right arrowOA All Versions of this Article:
37/16/5353    most recent
gkp582v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Rizzo, A.
Right arrow Articles by Biroccio, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rizzo, A.
Right arrow Articles by Biroccio, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2009 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Genome Integrity, Repair and Replication

Stabilization of quadruplex DNA perturbs telomere replication leading to the activation of an ATR-dependent ATM signaling pathway

Angela Rizzo1, Erica Salvati1,2, Manuela Porru1, Carmen D’Angelo1, Malcolm F. Stevens3, Maurizio D’Incalci4, Carlo Leonetti1, Eric Gilson2, Gabriella Zupi1 and Annamaria Biroccio1,*

1Department of Experimental Chemotherapy, Regina Elena Cancer Institute, Via delle Messi d’Oro 156, 00158 Rome, Italy, 2Laboratory of Molecular Biology of the Cell, CNRS, Ecole Normale Supérieure de Lyon, UMR5239, IFR128, 46 allée d'Italie, 69364 Lyon, France, 3Center for Biomolecular Sciences, School of Pharmacy, University of Nottingham, University Park, NG7 2RD Nottingham, UK and 4Department of Oncology, Pharmacological Research Institute ‘Mario Negri’, Via La Masa 19, 20156 Milan, Italy

*To whom correspondence should be addressed. Tel: +39 06 52662569; Fax: +39 06 52662505; Email: biroccio{at}ifo.it

Received May 20, 2009. Revised June 19, 2009. Accepted June 24, 2009.

Functional telomeres are required to maintain the replicative ability of cancer cells and represent putative targets for G-quadruplex (G4) ligands. Here, we show that the pentacyclic acridinium salt RHPS4, one of the most effective and selective G4 ligands, triggers damages in cells traversing S phase by interfering with telomere replication. Indeed, we found that RHPS4 markedly reduced BrdU incorporation at telomeres and altered the dynamic association of the telomeric proteins TRF1, TRF2 and POT1, leading to chromosome aberrations such as telomere fusions and telomere doublets. Analysis of the molecular damage pathway revealed that RHPS4 induced an ATR-dependent ATM signaling that plays a functional role in the cellular response to RHPS4 treatment. We propose that RHPS4, by stabilizing G4 DNA at telomeres, impairs fork progression and/or telomere processing resulting in telomere dysfunction and activation of a replication stress response pathway. The detailed understanding of the molecular mode of action of this class of compounds makes them attractive tools to understand telomere biology and provides the basis for a rational use of G4 ligands for the therapy of cancer.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.